We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-15.79%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$16.4B
AUM Growth
+$4.51B
Cap. Flow
+$7.45B
Cap. Flow %
45.53%
Top 10 Hldgs %
3.04%
Holding
4,763
New
1,229
Increased
1,758
Reduced
1,274
Closed
428

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$71M
2
BAC icon
Bank of America
BAC
+$53.3M
3
MPC icon
Marathon Petroleum
MPC
+$49.5M
4
ILMN icon
Illumina
ILMN
+$47.8M
5
NKE icon
Nike
NKE
+$44.9M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$43.1M
2
ZTS icon
Zoetis
ZTS
+$33.2M
3
CL icon
Colgate-Palmolive
CL
+$25.5M
4
QCOM icon
Qualcomm
QCOM
+$23.7M
5
FRC
First Republic Bank
FRC
+$23.1M

Sector Composition

Rank Sector Weight
1 Financials 15.38%
2 Technology 14.53%
3 Consumer Discretionary 10.24%
4 Healthcare 9.93%
5 Industrials 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDZNW icon
4051
Roadzen Inc Warrants
RDZNW
$8.64M
$66K ﹤0.01%
413,997
-6,653
-2% -$1.47K
UEC icon
4052
Uranium Energy
UEC
$5.57B
$66K ﹤0.01%
21,426
-13,431
-39% -$55.8K
TEO icon
4053
Telecom Argentina
TEO
$5.96B
$65K ﹤0.01%
+14,178
New +$77.1K
CRECW
4054
DELISTED
Crescera Capital Acquisition Corp Warrant
CRECW
$65K ﹤0.01%
352,367
-1,400
-0.4% -$329
DSP icon
4055
Viant Technology
DSP
$265M
$64K ﹤0.01%
12,600
+1,308
+12% +$7.84K
JNCE
4056
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$64K ﹤0.01%
20,975
+8,484
+68% +$41.3K
SMED
4057
DELISTED
Sharps Compliance Corp
SMED
$64K ﹤0.01%
22,028
+10,547
+92% +$44K
HUMA icon
4058
Humacyte
HUMA
$194M
$63K ﹤0.01%
19,500
-28,775
-60% -$160K
TIPT icon
4059
Tiptree Inc
TIPT
$675M
$63K ﹤0.01%
5,924
+4,241
+252% +$47.6K
KODK icon
4060
Kodak
KODK
$983M
$62K ﹤0.01%
13,398
-5,936
-31% -$31K
OMER icon
4061
Omeros
OMER
$959M
$62K ﹤0.01%
22,530
-234,813
-91% -$796K
ASMB icon
4062
Assembly Biosciences
ASMB
$529M
$61K ﹤0.01%
+2,413
New +$55.5K
AUTL
4063
Autolus Therapeutics
AUTL
$562M
$61K ﹤0.01%
+21,487
New +$65.4K
DAKT icon
4064
Daktronics
DAKT
$1.04B
$61K ﹤0.01%
20,421
-64,856
-76% -$217K
GWH icon
4065
ESS Tech
GWH
$18.9M
$61K ﹤0.01%
1,440
-2,933
-67% -$206K
HIVE
4066
HIVE Digital Technologies
HIVE
$777M
$61K ﹤0.01%
20,335
+1,214
+6% +$7.02K
ORIC icon
4067
Oric Pharmaceuticals
ORIC
$1.4B
$60K ﹤0.01%
13,416
-62,183
-82% -$248K
SPRY icon
4068
ARS Pharmaceuticals
SPRY
$612M
$60K ﹤0.01%
14,159
-22,122
-61% -$77.1K
PRLHW
4069
DELISTED
Pearl Holdings Acquisition Corp Warrant
PRLHW
$60K ﹤0.01%
377,087
NHICW
4070
DELISTED
NewHold Investment Corp. II Warrant
NHICW
$60K ﹤0.01%
302,439
-14,060
-4% -$3.48K
ATCX
4071
DELISTED
Atlas Technical Consultants, Inc. Class A Common Stock
ATCX
$60K ﹤0.01%
11,384
-2,243
-16% -$21.2K
RDNT icon
4072
RadNet
RDNT
$5.69B
$59K ﹤0.01%
3,443
+2,217
+181% +$43.1K
SOAR.WS
4073
DELISTED
Volato Group, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
SOAR.WS
$59K ﹤0.01%
589,696
SBDS
4074
DELISTED
Solo Brands Inc
SBDS
$59K ﹤0.01%
361
-105
-23% -$22.9K
PED icon
4075
PEDEVCO
PED
$141M
$58K ﹤0.01%
+2,515
New +$64.4K

Similar funds

Cubist Systematic Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, Cubist Systematic Strategies held 4,763 positions worth $16.4B, up 38% from $11.8B the previous quarter. Its ten largest holdings account for 3% of the portfolio.

Cubist Systematic Strategies deployed $7.45B of net new capital in Q2 2022, opening 1,229 new positions and adding to 1,758 existing holdings. Its largest new stake was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Verizon, an estimated $43.1M trimmed.

  • Cubist Systematic Strategies's largest Q2 2022 buy was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.
  • Cubist Systematic Strategies added most to American Express in Q2 2022, an estimated $71M increase.
  • Cubist Systematic Strategies's biggest Q2 2022 reduction was Verizon, cutting an estimated $43.1M.
  • Cubist Systematic Strategies fully exited UnitedHealth in Q2 2022, selling an estimated $17.1M.
  • Cubist Systematic Strategies's ten largest holdings make up 3% of its $16.4B portfolio in Q2 2022.
  • Cubist Systematic Strategies opened 1,229 new positions and closed 428 in Q2 2022.
  • Cubist Systematic Strategies's portfolio value rose 38% quarter-over-quarter to $16.4B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.